CHRU Lille

Running trials

• Recruiting

  ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

  NCT07545512· Source

• Recruiting

  Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

  NCT07493395· Phase 2· Source

• Recruiting

  Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents

  NCT05126914· Source

• Recruiting

  Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

  NCT07205731· Phase 2· Source

• Recruiting

  Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

  NCT06960902· Source

• Not yet recruiting

  Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France

  NCT07038863· Source

• Recruiting

  French Validation of Schizophrenia Proneness Instrument- Child Youth

  NCT06649552· Source

• Recruiting

  Epidemiological Data on Mast Cell Pathologies in France

  NCT06186856· Source

• Recruiting

  Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

  NCT05280314· Phase 2· Source

• Recruiting

  PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

  NCT05581121· Phase 3· Source

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Source

• Recruiting

  Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

  NCT06130787· Source

• Recruiting

  Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

  NCT05917405· Phase 2· Source

• Active, not recruiting

  ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

  NCT05928416· Source

• Active, not recruiting

  Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)

  NCT04866680· Source

• Recruiting

  Met Non Small Cell Cancer Registry (MOMENT)

  NCT05376891· Source

• Active, not recruiting

  Observatory of Patients With Haemophilia B Treated by IdElvion®

  NCT05086575· Source

• Active, not recruiting

  Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

  NCT04823377· Source

• Recruiting

  Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy

  NCT04767048· Phase 2· Source

• Recruiting

  Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy

  NCT04802135· Source

• Recruiting

  Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

  NCT04356326· Phase 3· Source

• Recruiting

  Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer

  NCT04528420· Source

• Active, not recruiting

  Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

  NCT03498040· Source

• Enrolling by invitation

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Source

• Recruiting

  COsegregation of VARiants in Panel of Genes

  NCT01689584· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Head and neck cancer3 recruiting
• Acute myeloid leukemia2 recruiting
• Coronary artery disease2 recruiting
• Epilepsy2 recruiting
• Cervical cancer1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Gastric and esophageal cancer1 recruiting
• Hepatitis B1 recruiting
• High blood pressure1 recruiting
• Liver and biliary tract cancer1 recruiting
• Melanoma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Rheumatoid arthritis1 recruiting
• Schizophrenia1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

  NCT05590377· Phase 1/2· Source

• Completed

  Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients

  NCT04912687· Source

• Terminated

  HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT03850795· Phase 3· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Source

• Completed

  A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

  NCT04266795· Phase 2· Source

• Completed

  Does OCT Optimise Results of Stenting on the Left Main Stem

  NCT04391413· Source

• Terminated

  Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)

  NCT04289805· Phase 4· Source

• Completed

  Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

  NCT03445845· Phase 4· Source

• Completed

  Register of Patients With haEmophilia A tReated With Afstyla®

  NCT04675541· Source

• Completed

  Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

  NCT03594149· Phase 3· Source

• Completed

  Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

  NCT02676349· Phase 2· Source